Back to search

Axalbion Therapeutics Limited

13224059

active
Private Limited Company
england wales
Companies House
Health Score
76 / 100

Some Concerns

30/30
Filing
10/30
Financial
36/40
Risk
  • Current liabilities exceed current assets (-10)
  • 2 outstanding charges (-4)

Details

3RD FLOOR, ALTRINCHAM, WA14 2DT
Incorporated 24/02/2021

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 15/05/2026

Due 29/05/2027

On track

Industry

21100
Manufacture of basic pharmaceutical products

Officers

Professor Ashley Arthur Woodcock

director · Since 24/02/2021

PROFESSOR OF MEDICINE

BRITISH · ENGLAND · Age 75

Also on 1 other board

Mr. Adrian Ivery Field

director · Since 16/03/2021

INVESTMENT DIRECTOR

BRITISH · UNITED KINGDOM · Age 52

Also on 10 other boards

Paul Hartley Glyer

director · Since 16/03/2021

HEALTHCARE EXECUTIVE

AMERICAN · UNITED STATES · Age 69

Thomas Courtney

director · Since 05/04/2024

BUSINESS EXECUTIVE

AMERICAN · UNITED STATES · Age 62

Stephanie Crispin Read

director · Since 02/07/2026

AMERICAN · UNITED STATES · Age 50

Former

Michael Kitt

director · Resigned 22/12/2025

Persons with Significant Control

Mr Jonathan Paul Moulton

50–75% shares
50–75% votes
Appoint directors

British · Guernsey · Age 75

Trafalgar Court, 2nd Floor, East Wing, Guernsey, GY1 3EL

Notified 16/03/2021

Former PSCs

Professor Ashley Arthur Woodcock

Ceased 16/03/2021

Charges2 outstanding

A registered charge
outstanding

HSBC INNOVATION BANKING

Created 12/08/2026Registered 17/08/2026
A registered charge
outstanding

HSBC INNOVATION BANKING

Created 12/08/2026Registered 17/08/2026
Charge
satisfied

MOULTON GOODIES LIMITED

Created 20/10/2023Registered 25/10/2023Satisfied 08/04/2024
Charge
satisfied

MOULTON GOODIES LIMITED

Created 27/02/2023Registered 01/03/2023Satisfied 08/04/2024

CompanyRankvs 113+ SIC 21100 peers
68

Financial strength95th percentile among SIC peers · 24/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio 5.86× · 20/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£4.9M

Balance sheet strength

Cash

£2.5M

Cash in the bank

Net Current Assets

£2.3M

Working capital

Current Assets

£2.8M

Current Liabilities

£470k

Fixed Assets

£4.3M

Debtors

£253k

Profit After Tax

-£5.4M

7avg. employees

Balance Sheet

Intangible assets£1.5M
Assets less current liabilities£6.5M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20255.86+£1.4M
20233.27

Derived from filed accounts. Not audited figures.